Market revenue in 2023 | USD 75.2 million |
Market revenue in 2030 | USD 132.7 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | Clinical Trial Design and Consultation Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.86% in 2023. Horizon Databook has segmented the Germany clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
The German clinical trial imaging market is anticipated to grow at the fastest growth rate over the forecast period. This can be attributed to aging population, prevalence of chronic diseases, presence of a sophisticated healthcare system, highly qualified workforce, and high healthcare spending.
The industry of medical technology in Germany is highly innovative and dynamic. Sales of devices that are less than 3 years old have generated one-third of the total sales, and approximately 9% of all sales are reinvested in research.
German Medical Products Law (MPG) of 1995 was revised in July 2014 and was applicable to all devices, equipment, materials, & instruments that are used on or in the human body and are relevant when seeking permission to enter the German market.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into Germany clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account